Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 400

1.

Psychotropic drug use in community-dwelling people with young-onset dementia: two-year course and determinants.

Gerritsen AAJ, Bakker C, Bruls E, Verhey FRJ, Pijnenburg YAL, Millenaar JK, de Vugt ME, Koopmans RTCM.

Aging Ment Health. 2019 Nov 20:1-8. doi: 10.1080/13607863.2019.1691145. [Epub ahead of print]

PMID:
31746238
2.

Microvascular Dysfunction Is Associated With Worse Cognitive Performance: The Maastricht Study.

Rensma SP, van Sloten TT, Houben AJHM, Köhler S, van Boxtel MPJ, Berendschot TTJM, Jansen JFA, Verhey FRJ, Kroon AA, Koster A, Backes WH, Schaper N, Dinant GJ, Schalkwijk CG, Henry RMA, Wolfs EML, van Heumen MJA, Schram MT, Stehouwer CDA.

Hypertension. 2019 Nov 18:HYPERTENSIONAHA11913023. doi: 10.1161/HYPERTENSIONAHA.119.13023. [Epub ahead of print]

PMID:
31735081
3.

Linking APOE-ε4, blood-brain barrier dysfunction, and inflammation to Alzheimer's pathology.

Riphagen JM, Ramakers IHGM, Freeze WM, Pagen LHG, Hanseeuw BJ, Verbeek MM, Verhey FRJ, Jacobs HIL.

Neurobiol Aging. 2019 Oct 15. pii: S0197-4580(19)30355-0. doi: 10.1016/j.neurobiolaging.2019.09.020. [Epub ahead of print]

4.

White matter hyperintensities mediate the association between blood-brain barrier leakage and information processing speed.

Freeze WM, Jacobs HIL, de Jong JJ, Verheggen ICM, Gronenschild EHBM, Palm WM, Hoff EI, Wardlaw JM, Jansen JFA, Verhey FR, Backes WH.

Neurobiol Aging. 2019 Sep 27. pii: S0197-4580(19)30338-0. doi: 10.1016/j.neurobiolaging.2019.09.017. [Epub ahead of print]

PMID:
31718926
5.

Performance and Symptom Validity Assessment in Patients with Apathy and Cognitive Impairment.

Dandachi-FitzGerald B, Duits AA, Leentjens AFG, Verhey FRJ, Ponds RWHM.

J Int Neuropsychol Soc. 2019 Oct 29:1-8. doi: 10.1017/S1355617719001139. [Epub ahead of print]

PMID:
31658930
6.

Cost-consequence analysis of an intervention for the management of neuropsychiatric symptoms in young-onset dementia: Results from the BEYOND-II study.

van Duinen-van den IJssel JCL, Bakker C, Smalbrugge M, Zwijsen SA, Adang E, Appelhof B, Zuidema SU, de Vugt ME, Verhey FRJ, Koopmans RTCM.

Int J Geriatr Psychiatry. 2020 Jan;35(1):131-137. doi: 10.1002/gps.5229. Epub 2019 Nov 7.

PMID:
31657080
7.

Determinants of Cross-Sectional and Longitudinal Health-Related Quality of Life in Memory Clinic Patients Without Dementia.

Banning LCP, Janssen EPCJ, Hamel REG, de Vugt M, Köhler S, Wolfs CAG, Oosterveld SM, Melis RJF, Olde Rikkert MGM, Kessels RPC, Pijnenburg YAL, Koene T, van der Flier WM, Scheltens P, Visser PJ, Verhey FRJ, Aalten P, Ramakers IHGB.

J Geriatr Psychiatry Neurol. 2019 Oct 23:891988719882104. doi: 10.1177/0891988719882104. [Epub ahead of print]

PMID:
31645191
8.

Affective symptoms and AT(N) biomarkers in mild cognitive impairment and Alzheimer's disease: A systematic literature review.

Banning LCP, Ramakers IHGB, Deckers K, Verhey FRJ, Aalten P.

Neurosci Biobehav Rev. 2019 Dec;107:346-359. doi: 10.1016/j.neubiorev.2019.09.014. Epub 2019 Sep 13. Review.

9.

Modifiable Risk Factors Explain Socioeconomic Inequalities in Dementia Risk: Evidence from a Population-Based Prospective Cohort Study.

Deckers K, Cadar D, van Boxtel MPJ, Verhey FRJ, Steptoe A, Köhler S.

J Alzheimers Dis. 2019;71(2):549-557. doi: 10.3233/JAD-190541.

10.

In vivo imaging of the nucleus of the solitary tract with Magnetization Transfer at 7 Tesla.

Priovoulos N, Poser BA, Ivanov D, Verhey FRJ, Jacobs HIL.

Neuroimage. 2019 Nov 1;201:116071. doi: 10.1016/j.neuroimage.2019.116071. Epub 2019 Aug 6.

PMID:
31398435
11.

Optimal Detection of Subtle Gadolinium Leakage in CSF with Heavily T2-Weighted Fluid-Attenuated Inversion Recovery Imaging.

Freeze WM, Ter Weele DN, Palm WM, van Hooren RW, Hoff EI, Jansen JFA, Jacobs HIL, Verhey FR, Backes WH.

AJNR Am J Neuroradiol. 2019 Sep;40(9):1481-1483. doi: 10.3174/ajnr.A6145. Epub 2019 Aug 8.

PMID:
31395665
12.

The necessity for sustainable intervention effects: lessons-learned from an experience sampling intervention for spousal carers of people with dementia.

Bartels SL, van Knippenberg RJM, Köhler S, Ponds RW, Myin-Germeys I, Verhey FRJ, de Vugt ME.

Aging Ment Health. 2019 Aug 1:1-11. doi: 10.1080/13607863.2019.1647130. [Epub ahead of print]

PMID:
31368355
13.

Association Between Proxy- or Self-Reported Cognitive Decline and Cognitive Performance in Memory Clinic Visitors.

Gruters AAA, Ramakers IHGB, Verhey FRJ, Köhler S, Kessels RPC, de Vugt ME.

J Alzheimers Dis. 2019;70(4):1225-1239. doi: 10.3233/JAD-180857.

PMID:
31322557
14.

Cognitive and functional progression of dementia in two longitudinal studies.

Wang Y, Haaksma ML, Ramakers IHGB, Verhey FRJ, van de Flier WM, Scheltens P, van Maurik I, Olde Rikkert MGM, Leoutsakos JS, Melis RJF.

Int J Geriatr Psychiatry. 2019 Nov;34(11):1623-1632. doi: 10.1002/gps.5175. Epub 2019 Jul 26.

15.

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.

Vermunt L, Sikkes SAM, van den Hout A, Handels R, Bos I, van der Flier WM, Kern S, Ousset PJ, Maruff P, Skoog I, Verhey FRJ, Freund-Levi Y, Tsolaki M, Wallin ÅK, Olde Rikkert M, Soininen H, Spiru L, Zetterberg H, Blennow K, Scheltens P, Muniz-Terrera G, Visser PJ; Alzheimer Disease Neuroimaging Initiative; AIBL Research Group; ICTUS/DSA study groups.

Alzheimers Dement. 2019 Jul;15(7):888-898. doi: 10.1016/j.jalz.2019.04.001. Epub 2019 Jun 1.

PMID:
31164314
16.

Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms.

Jacobs HIL, Riphagen JM, Ramakers IHGB, Verhey FRJ.

Mol Psychiatry. 2019 May 28. doi: 10.1038/s41380-019-0437-x. [Epub ahead of print]

PMID:
31138892
17.

Development of memory clinics in the Netherlands over the last 20 years.

Gruters AAA, Ramakers IHGB, Kessels RPC, Bouwman FH, Olde Rikkert MGM, Blom MM, de Vugt ME, Verhey FRJ.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1267-1274. doi: 10.1002/gps.5132. Epub 2019 May 20.

18.

Importance of Social Support Within the Nursing Staff on Agitation in Residents With Dementia.

Tan EYL, de Vugt ME, Köhler S, Verhey FRJ, Schols JMGA.

J Am Med Dir Assoc. 2019 Jun;20(6):785-786. doi: 10.1016/j.jamda.2019.03.002. Epub 2019 Apr 16. No abstract available.

PMID:
31003932
19.

Effects on staff outcomes from an intervention for management of neuropsychiatric symptoms in residents of young-onset dementia care units: A cluster randomised controlled trial.

van Duinen-van den IJssel JCL, Bakker C, Smalbrugge M, Zwijsen SA, Appelhof B, Teerenstra S, Zuidema SU, de Vugt ME, Verhey FRJ, Koopmans RTCM.

Int J Nurs Stud. 2019 Aug;96:35-43. doi: 10.1016/j.ijnurstu.2019.03.006. Epub 2019 Mar 15.

PMID:
30979401
20.

Prevalence and correlates of psychotropic drug use in Dutch nursing home patients with young-onset dementia.

Mulders AJMJ, Zuidema SU, Leeuwis R, Bor H, Verhey FRJ, Koopmans RTCM.

Int J Geriatr Psychiatry. 2019 Aug;34(8):1185-1193. doi: 10.1002/gps.5116. Epub 2019 Apr 29.

Supplemental Content

Loading ...
Support Center